Two Sigma Investments
MBIO icon

Two Sigma Investments’s Mustang Bio MBIO Stock Holding History

Two Sigma Investments’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2K Sell
16,754
-23,280
-58% -$21.9K ﹤0.01% 4523
2025
Q4 		$39.3K Buy
+40,034
New +$52.9K ﹤0.01% 3958
2025
Q1 		– Sell
-814
Closed -$7.2K – 3382
2024
Q4 		$7.2K Buy
+814
New +$8.99K ﹤0.01% 3141
2023
Q2 		– Sell
-121
Closed -$33.2K – 3164
2023
Q1 		$33.2K Sell
121
-32
-21% -$13.1K ﹤0.01% 2801
2022
Q4 		$45.3K Sell
153
-29
-16% -$9.9K ﹤0.01% 2605
2022
Q3 		$64K Sell
182
-104
-36% -$48.2K ﹤0.01% 2290
2022
Q2 		$126K Sell
286
-356
-55% -$197K ﹤0.01% 2242
2022
Q1 		$486K Sell
642
-321
-33% -$264K ﹤0.01% 2027
2021
Q4 		$1.2M Sell
963
-302
-24% -$488K ﹤0.01% 2387
2021
Q3 		$2.55M Sell
1,265
-524
-29% -$1.13M 0.01% 1753
2021
Q2 		$4.45M Buy
1,789
+1,058
+145% +$2.59M 0.01% 1272
2021
Q1 		$1.82M Buy
731
+497
+212% +$1.48M ﹤0.01% 1782
2020
Q4 		$664K Sell
234
-240
-51% -$574K ﹤0.01% 2300
2020
Q3 		$1.12M Buy
474
+457
+2,688% +$1.13M ﹤0.01% 1677
2020
Q2 		$41K Buy
+17
New +$39.7K ﹤0.01% 2848

Other funds holding MBIO

KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CG
CFO4Life Group Coppell, Texas $656M AUM 17.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Two Sigma Investments's MBIO Position: Q1 2026 in Review

Two Sigma Investments reduced its Mustang Bio (MBIO) stake by 58% in Q1 2026, selling an estimated $21.9K and leaving 16,754 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4523.

Two Sigma Investments first reported a position in MBIO in Q2 2020 and has held it in 15 quarters since. The position peaked at $4.45M in Q2 2021. 22 funds tracked by Wall St. Rank hold MBIO as of Q1 2026.

  • Two Sigma Investments held 16,754 shares of Mustang Bio worth $12.2K as of Q1 2026.
  • Two Sigma Investments sold 23,280 Mustang Bio shares in Q1 2026, an estimated $21.9K.
  • Mustang Bio made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4523 holding.
  • Two Sigma Investments first reported a position in Mustang Bio in Q2 2020 and has held it in 15 quarters since.
  • Two Sigma Investments's Mustang Bio position peaked at $4.45M in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.